| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026170475 |
| P356 | DOI | 10.1046/J.0022-202X.2001.01379.X |
| P698 | PubMed publication ID | 11442751 |
| P5875 | ResearchGate publication ID | 232784421 |
| P50 | author | Alan J Russell | Q59682640 |
| Paul Speight | Q88443127 | ||
| Mark P. Lewis | Q39493092 | ||
| P2093 | author name string | Hart IR | |
| Sheppard D | |||
| Marshall JF | |||
| Whawell SA | |||
| Thomas GJ | |||
| P2860 | cites work | Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 |
| P4510 | describes a project that uses | H357-V3 | Q54992480 |
| H357-VB6 | Q54992947 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 67-73 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells | |
| P478 | volume | 117 |
| Q39251935 | A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo |
| Q39093483 | ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin. |
| Q36360521 | Alphavbeta6 integrin in wound healing and cancer of the oral cavity |
| Q37903910 | An overview of the molecular pathology of head and neck cancer, and its clinical implications. |
| Q24803786 | Antiangiogenic gene therapy of cancer: recent developments |
| Q37144740 | Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer |
| Q45170033 | Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. |
| Q36646138 | Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells |
| Q33768197 | Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer |
| Q92043646 | CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies |
| Q34503793 | Cell adhesion molecules and oral cancer |
| Q90091615 | Characterization of Porphyromonas gingivalis sialidase and disruption of its role in host-pathogen interactions |
| Q28512501 | Characterization of integrin beta6 and thrombospondin-1 double-null mice |
| Q39588142 | Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion |
| Q87913141 | Clinical significance of integrin β6 as a tumor recurrence factor in follicular thyroid carcinoma |
| Q100454978 | Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells |
| Q39706819 | Development of a quantitative method to analyse tumour cell invasion in organotypic culture |
| Q39909899 | Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma. |
| Q42442171 | Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development |
| Q33686825 | Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect. |
| Q54380363 | E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. |
| Q39957224 | Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus |
| Q36674650 | Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels |
| Q40732304 | Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma |
| Q45222837 | GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness |
| Q44648580 | Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells |
| Q58195203 | HS1-Associated Protein X-1 Regulates Carcinoma Cell Migration and Invasion via Clathrin-Mediated Endocytosis of Integrin αvβ6 |
| Q36918650 | High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers. |
| Q37232834 | In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. |
| Q40101635 | Inducible nitric oxide synthase: correlation with extracapsular spread and enhancement of tumor cell invasion in head and neck squamous cell carcinoma |
| Q37643500 | Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis |
| Q30480583 | Integrin-linked kinase is required for epidermal and hair follicle morphogenesis |
| Q38285373 | Integrin-mediated adhesion and mechano-sensing in cutaneous wound healing. |
| Q36349943 | Integrins in head and neck squamous cell carcinoma (HNSCC): a review of the current literature |
| Q37522945 | Internalization of Staphylococcus aureus by human keratinocytes. |
| Q41016131 | Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy. |
| Q34992326 | Involvement of cholangiocyte proliferation in biliary fibrosis |
| Q90586177 | Loss of S100A14 expression at the tumor-invading front correlates with poor differentiation and worse prognosis in oral squamous cell carcinoma |
| Q33496895 | MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells |
| Q39626691 | MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. |
| Q31096250 | NMR relaxation and structural elucidation of peptides in the presence and absence of trifluoroethanol illuminates the critical molecular nature of integrin αvβ6 ligand specificity |
| Q48125956 | Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. |
| Q34047996 | Pathophysiology of fistula formation in Crohn's disease |
| Q39949731 | Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers |
| Q39623720 | Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. |
| Q40788935 | Q2DSTD NMR deciphers epitope-mapping variability for peptide recognition of integrin αvβ6. |
| Q39738881 | Reduced transforming growth factor β1 (TGF-β1) in the repair of airway epithelial cells of children with asthma |
| Q35006163 | S100A14 interacts with S100A16 and regulates its expression in human cancer cells. |
| Q28586573 | SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration |
| Q34946977 | Structural guided scaffold phage display libraries as a source of bio-therapeutics |
| Q40179951 | Structure-function analysis of Arg-Gly-Asp helix motifs in alpha v beta 6 integrin ligands |
| Q39020546 | Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function. |
| Q38383977 | Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC. |
| Q42915643 | Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis |
| Q33444443 | Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications |
| Q37603527 | Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells |
| Q46889961 | The 120 kDa cell-binding fragment of fibronectin up-regulates migration of alphavbeta6-expressing cells by increasing matrix metalloproteinase-2 and -9 secretion. |
| Q36429644 | The alphaVbeta6 integrin as a novel molecular target for colorectal cancer |
| Q40289291 | The immunohistology of CD40 in human oral epithelium in health and disease |
| Q40569756 | The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9. |
| Q93153842 | The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy |
| Q39536007 | The role of α9β1 integrin in modulating epithelial cell behaviour. |
| Q40314864 | Transfection and ligation of CD40 in human oral keratinocytes affect proliferation, adhesion and migration but not apoptosis in vitro |
| Q40325737 | Transfection of CD40 in a human oral squamous cell carcinoma keratinocyte line upregulates immune potency and costimulatory molecules |
| Q38806280 | Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells |
| Q28237180 | Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells |
| Q45122173 | beta1-Integrins mediate enhancement of airway smooth muscle proliferation by collagen and fibronectin |
| Q34683204 | β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition |
Search more.